MedTrace Logo

Early Onset and Familial Gastric Cancer Registry

NCT00582257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 971

Last updated 2024-10-03

No results posted yet for this study

Summary

The purpose of this study is to establish a gastric cancer registry. A registry is a database of information. With the registry, we can learn more about the genetic causes of gastric cancer in order to develop better methods of early diagnosis, prevention, and treatment of gastric cancers. As part of this study, you will be asked to join a registry of families who are affected with various forms of gastric cancer. These registries are important because they may help physicians better manage gastric cancer now and in the future. Participating in the Early Onset and Familial Gastric Cancer Registry can also be educational for families, since it will provide important information to patients, families, and physicians. All of this will help to further our understanding of genetic causes of gastric cancer and eventually, help determine better ways to diagnose, treat, and survey patients with gastric cancer and people who may have a higher risk for gastric cancer.

Conditions

Interventions

BEHAVIORAL

questionnaires

Participation in the registry will consist of adequately completing the family history questionnaire (one per family) the gastric cancer risk factor questionnaire and providing a blood sample for future correlative studies. Registry participants (both Patient/Relative and Control cohorts) will be required to submit tissue (both normal and/or tumor) to create a Tissue and DNA repository. Select participants will be invited to undergo Genetic Counseling, eg. those participants who meet clinical criteria for HDGC.

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER

  • Queens Health Network

    collaborator OTHER

  • University of Southern California

    collaborator OTHER

  • Shaare Zedek Medical Center

    collaborator OTHER

  • Obafemi Awolowo University Teaching Hospital

    collaborator OTHER

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • David Kelsen, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-13
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • United States
  • Nigeria

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00582257 on ClinicalTrials.gov